https://www.selleckchem.com/pr....oducts/Menadione.htm
e-health tool on patient data showed a strong relationship between the panel recommendations and both SCS trial results and treatment outcomes. Spinal cord stimulation (SCS) is considered a minimally invasive and reversible neuromodulation therapy for various chronic pain disorders. The rates of infection following SCS surgery reported in the literature range from 2.8% to 10%. Several studies indicated no potential benefit of postoperative antibiotics (beyond 24 hours) on subsequent device infection. This study aimed to understand the